Consultation on simplifying UK medicines legislation

3 January 2012

This review is part of a laudable process to simplify regulation and make it easier for companies and other organisations to understand and comply with legal requirements in this area. It comes at a time when smaller pharmaceutical and biotechnology companies are reportedly increasingly outsourcing clinical trials and bringing products to market to other companies that understand and can navigate the complex regulatory process more easily. 

More from us

Genomics and policy news